Details on our highly-anticipated report, plus a free pick for you...
Could big wins for these big pharma stocks in 2018 translate to more big returns?
It's a well-known fact that U.S. companies offer mediocre dividend yields. But if you cast the net a bit wider, you can land much larger payouts overseas.
Expect some good news from these three companies.
I'm going to show you a chart that will tell us if this is simply a market correction or a sign of more ominous things to come.
Square's business keeps growing, and the best could be yet to come.
The Oracle of Omaha has made his billions with these timeless investing principles.
After a decade of domination, growth stocks may once again take a back seat to value stocks.
He may not be as famous as Warren Buffett or Peter Lynch, but this little-known professor made his mark by coming up with a nifty way of identifying undervalued stocks...
Crude oil prices have fallen back to where they were at this time last year, which is quite a tumble from their recent peaks.